Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by by grants from the Instituto de Investigacin Carlos III, ISCIII, (FIS PI1801007 and PI2100989), by the European Commission Horizon 2020 Framework Programme: Project VIRUSCAN FETPROACT-2016: 731868, Horizon Europe Framework programme: Project EPIC-CROWN-2 ID: 101046084 and by Fundacion Caixa-Health Research (Project StopEbola HR18-00469) to RD. M.M-L holds a clinical research contract Rio Hortega (CM19/00226) from the Instituto de Salud Carlos III, ISCIII (Spanish Ministry of Science, Innovation and Universities)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Comite Etico de Investigacion Medica (IRB) Hospital Universitario 12 de Octubre. Ref CEIm 20/157

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes